MARKET

IMNN

IMNN

Imunon Inc
NASDAQ
3.880
-0.090
-2.27%
After Hours: 3.820 -0.06 -1.55% 16:11 12/16 EST
OPEN
3.990
PREV CLOSE
3.970
HIGH
3.990
LOW
3.801
VOLUME
25.49K
TURNOVER
--
52 WEEK HIGH
47.40
52 WEEK LOW
3.560
MARKET CAP
11.91M
P/E (TTM)
-0.3804
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMNN last week (1208-1212)?
Weekly Report · 1d ago
Weekly Report: what happened at IMNN last week (1201-1205)?
Weekly Report · 12/08 10:11
Weekly Report: what happened at IMNN last week (1124-1128)?
Weekly Report · 12/01 10:07
Weekly Report: what happened at IMNN last week (1117-1121)?
Weekly Report · 11/24 10:11
Weekly Report: what happened at IMNN last week (1110-1114)?
Weekly Report · 11/17 10:11
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices
TipRanks · 11/16 06:01
Alliance Global Partners Remains a Buy on Imunon (IMNN)
TipRanks · 11/14 12:35
IMUNON, Inc. Reports Q3 2025 Results and Progress
TipRanks · 11/14 04:28
More
About IMNN
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

Webull offers Imunon Inc stock information, including NASDAQ: IMNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMNN stock methods without spending real money on the virtual paper trading platform.